United States
Australia
Brazil
Germany
India
Ireland
Japan
Mexico
New Zealand
Philippines
South Africa
United Kingdom
The Lancet Voice
From The Lancet Group
Health & Fitness
The Lancet Respiratory Medicine in conversation with
by The Lancet Group
Today: #158 in Health & Fitness, Japan on our combined chart.
Share this ranking
Claiming needs an RSS feed. Contact us.
Chart positions today · Canada
Not on the United States charts we track today.
Not on the United Kingdom charts we track today.
Not on the Canada charts we track today.
Not on the Australia charts we track today.
Not on the Germany charts we track today.
Not on the Brazil charts we track today.
Not on the Mexico charts we track today.
Not on the New Zealand charts we track today.
Not on the Ireland charts we track today.
Not on the India charts we track today.
Not on the Philippines charts we track today.
Not on the South Africa charts we track today.
If you like The Lancet Respiratory Medicine in…, try…
The Lancet Psychiatry in conversation with
From The Lancet Group
Stanford Emergency Medicine Podcast
Similar topics: medicine and care
Street Side: The Street Medicine Institute Podcast
Similar topics: medicine and health
The Future of Medicine
Also in Health & Fitness
Home of Medicine with Dr Amie Burbridge and Dr Ben Lovell
Also in Health & Fitness
Ranking history · Canada
No ranking history for this show in Canada over the last 7 days.
Latest episodes
-
Solange Peters, Lizza Hendricks, and Martin Reck on the changing treatment landscape in lung cancer
September 6, 2026 · 27 minSolange Peters, Lizza Hendricks, and Martin Reck join Jonathan Blott to discuss The Lancet Respiratory Medicine Series on therapeutics in lung cancer, published to coincide with the Series launch at ERS 2026. The Series reviews…
-
Andrew Bush, Heather Zar, Fernando de Benedictis on how inhaled corticosteroids have changed the treatment of asthma
June 15, 2026 · 13 minAndrew Bush, Heather Zar, Fernando de Benedictis talk about their recent personal view piece where they summarise and discuss the 50-year journey and evolution of inhaled corticosteroids (ICS) in asthma treatment. Click here to read the…
-
Anne-Marie Dingemans; Isabelle Opiz; Corinne Faivre-Finn on a consensus definition of stage III Non-Small Cell Lung Cancer technical resectability
March 26, 2026 · 28 minAnne-Marie Dingemans, Isabelle Opiz, and Corinne Faivre-Finn talk about their multidisciplinary efforts to develop a consensus definition of stage III Non-Small Cell Lung Cancer technical resectability. https://www.the…
-
Anne Holland and Christine McDonald
March 2, 2026 · 12 minAnne Holland and Christine McDonald join Diana Stanley to discuss ambulatory oxygen for treatment of exertional hypoxaemia in pulmonary fibrosis. Click here to read the full article, Ambulatory oxygen for treatment of exertional…
-
Marion Moseby-Knappe on Blood biomarkers for the prediction of outcome after cardiac arrest
December 22, 2025 · 8 minMarion Moseby-Knappe talks about a prospective, international, observational biomarker study, within the Targeted Hypothermia versus Normothermia after Out-of-Hospital Cardiac Arrest (TTM2) trial, to compare four markers of brain injury…
Show 7 more episodesShow fewer episodes
-
Sailesh Kotecha on Prematurity-associated lung disease
November 27, 2025 · 11 minProf Sailesh Kotecha joins Diana Stanley to discuss the series on reframing prematurity-associated lung disease as a continuum that begins before birth and evolves throughout life. Cick here to read the full series: Looking beyond…
-
Neil Greening and Hnin Aung on Multidimensional prognostic risk stratification of COPD exacerbations
November 25, 2025 · 15 minDr Neil Greening and Dr Hnin Aung join Diana Stanley to discuss a new multidimensional prognostic risk stratification model for COPD exacerbations. click here to read the full article: https://www.thelancet.com/journal…
-
Finn McQuaid and Matthew Saunders on Tuberculosis and Climate change
October 30, 2025 · 11 minDr Finn McQuaid and Dr Matthew Saunders join Arianna Colosio to discuss an analytical framework to describe potential causal relationships between climate change and tuberculosis. Click here to read the full article Continue this…
-
Guy Brusselle and Celeste Porsbjerg on State-of-the-art insights into prevention, development, and management of asthma
September 28, 2025 · 23 minProfessors Guy Brusselle and Celeste Porsbjerg join us to discuss their recent Series papers on asthma, which will be featured in a cross journal project with The Lancet, published to coincide with a Lancet journal session on asthma at ERS…
-
Toby Maher on ENV-101 in patients with idiopathic pulmonary fibrosis
September 28, 2025 · 9 minToby Maher joins us to discuss results of a randomised, double-blind, placebo-controlled, proof-of-concept trial of ENV-101, an oral inhibitor of the hedgehog signalling pathway, in patients with idiopathic pulmonary fibrosis. Read the…
-
Joan Soriano on Global Epidemiology of Respiratory Disease
July 17, 2025 · 11 minDiana Stanley, Deputy Editor at The Lancet Respiratory Medicine, is joined by Dr Joan Soriano to discuss a new series on the global epidemiology of respiratory disease, exploring the diagnostic challenges, global trends, and future…
-
Carole Mitnick & Lorenzo Guglielmetti on the ENDTB-Q trial
July 16, 2025 · 19 minCarole Mitnick & Lorenzo Guglielmetti join Ari Colosio, deputy editor of The Lancet Respiratory Medicine, to discuss the ENDTB-Q trial to evaluate the efficacy and safety of a drug regiment to treat TB in individuals with pre-extensively…
About the show
Editors at The Lancet Respiratory Medicine, in conversation with the journal’s authors, explore their latest research and its impact on people’s health, healthcare, and health policy.A monthly audio companion to the journal, this podcast covers a broad range of topics, from long COVID outcomes to tobacco control, the management of uncontrolled asthma to intensive care medicine, and more.